Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine
-
MK-801, a drastic decline in the expression of DAO mRNA is observed in most brain areas 1 h after the MK-801 administration (1.6 mg/kg)
1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
2,3-dioxo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine-7-carboxylic acid
-
-
3,3-dibromo-4-chloro-5-fluoro-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine
-
-
3-hydroxy-1,5-naphthyridin-2(1H)-one hydrobromide
-
-
3-hydroxy-1,6-naphthyridin-2(1H)-one hydrobromide
-
-
3-hydroxy-1,7-naphthyridin-2(1H)-one hydrobromide
-
-
3-hydroxy-1,8-naphthyridin-2(1H)-one
-
-
3-hydroxy-1,8-naphthyridin-2(1H)-one hydrobromide
-
-
3-hydroxy-4-methylquinolin-2(1H)-one
-
-
3-hydroxy-5-methylquinolin-2(1H)-one
-
-
3-hydroxy-6-methylquinolin-2(1H)-one
-
-
3-hydroxy-7-methylquinolin-2(1H)-one
-
-
3-hydroxy-8-methylquinolin-2(1H)-one
-
-
3-hydroxyquinolin-2(1H)-one
-
-
3-hydroxyquinolin-2-one
-
-
4-(trifluoromethyl)-1,2-benzisoxazol-3-ol
-
-
4-chloro-5-fluoro-1H-pyrrolo[2,3-b]pyridine-2,3-dione
-
-
4-fluoro-1,2-benzisoxazol-3-ol
-
-
4H-thieno [3,2-b]pyrrole-5-carboxylic acid
-
i.e. compound 8, a moderately potent inhibitor of rat DAAO in vitro, inhibits DAAO activity in kideny by 96% and in brain by 80% resulting in a significant elevation in both plasma and cerebrospinal fluid D-serine concentration. Compound 8 fails to significantly influence amphetamine-induced psychomotor activity, nucleus accumbens dopamine release, or a dizocilpine maleate-induced deficit in novel object recognition in rats
4H-thieno[3,2-b] pyrrole-5-carboxylic acid
-
i.e. compound 8, very specific inhibitor of DAAO. Compound 8 at 200 mg/kg body weight inhibits rat kidney and cerebellar DAAO by approximately 96% and 80%, respectively. Effects after in vivo application, overview
5-bromo-1,2-benzisoxazol-3-ol
-
-
5-chloro-3-hydroxyquinolin-2(1H)-one
-
-
5-chloro-6-fluoro-3-hydroxy-1,8-naphthyridin-2(1H)-one hydrobromide
-
-
5-chloro-6-fluoro-3-hydroxyquinolin-2(1H)-one
-
-
5-ethyl-3-hydroxyquinolin-2(1H)-one
-
-
5-fluoro-3-hydroxyquinolin-2(1H)-one
-
-
5-iodo-1,2-benzisoxazol-3-ol
-
-
5-methyl-1H-pyrazole-3-carboxylic acid
-
-
5-methylpyrazole-3-carboxylic acid
5-nitro-1,2-benzisoxazol-3-ol
-
-
6-(benzyloxy)-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
6-(trifluoromethyl)-1,2-benzisoxazol-3-ol
-
-
6-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
6-chloro-3-hydroxyquinolin-2(1H)-one
-
-
6-chlorobenzo(d)isoxazol-3-ol
-
-
6-chlorobenzo[d]isoxazol-3-ol
6-ethoxy-1,2-benzisoxazol-3-ol
-
-
6-ethoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione .
-
-
6-fluoro-1,2-benzisoxazol-3-ol
-
-
6-fluoro-3-hydroxyquinolin-2(1H)-one
-
-
6-methoxy-1,2-benzisoxazol-3-ol
-
-
6-methoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
6-methyl-1,2-benzisoxazol-3-ol
-
-
6-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
6-nitro-1,2-benzisoxazol-3-ol
-
-
6-phenethoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7,8-dibromo-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7,8-dichloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-bromo-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-bromo-8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-bromo-8-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-chloro-3-hydroxyquinolin-2(1H)-one
-
-
7-chloro-8-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-ethyl-3-hydroxyquinolin-2(1H)-one
-
-
7-fluoro-1,2-benzisoxazol-3-ol
-
-
7-fluoro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-fluoro-3-hydroxyquinolin-2(1H)-one
-
-
7-fluoro-6-(trifluoromethyl)-1,2-benzisoxazol-3-ol
-
-
7-fluoro-8-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-hydroxypyrido[2,3-b]pyrazin-6(5H)-one
-
-
7-methyl-1,2-benzisoxazol-3-ol
-
-
7-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
7-trifluoromethyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-(benzyloxy)-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-bromo-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-bromo-7-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
8-chloro-3-hydroxyquinolin-2(1H)-one
-
-
8-ethoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-ethyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-ethyl-3-hydroxyquinolin-2(1H)-one
-
-
8-fluoro-3-hydroxyquinolin-2(1H)-one
-
-
8-isopropoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-methoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-phenoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-phenylethoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-phenylpropoxy-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-trifluoromethyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
benzo[d]isoxazol-3-ol
-
-
methyl 2,3-dioxo-1,2,3,4-tetrahydropyrido[2,3-b]pyrazine-7-carboxylate
-
-
quinoxaline-2,3-dione
-
-
additional information
-
negligible DAAO inhibition with muscimol, (S)-AMPA, 6-chloro-3-methoxybenzo[d]isoxazole, and 4,5,6,7-tetrahydrobenzo[d]isoxazol-3-ol
-
5-methylpyrazole-3-carboxylic acid
-
AS057278, selective D-amino acid oxidase inhibitor, 10 mg/kg
5-methylpyrazole-3-carboxylic acid
-
i.e. AS057278
6-chlorobenzo[d]isoxazol-3-ol
-
-
6-chlorobenzo[d]isoxazol-3-ol
-
competitive
6-chlorobenzo[d]isoxazol-3-ol
-
potent, competitive inhibitor
8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
-
8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
-
potent inhibitor
benzoate
-
-
benzoate
-
potent competitive inhibitor
chlorpromazine
-
a non-specific DAO inhibitor
chlorpromazine
-
FAD-competitive inhibitor
Sodium benzoate
-
-
Sodium benzoate
-
competitive inhibitor, inhibits the development of mechanical allodynia, caused by enhanced enzyme expression, in the spinal cord, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.003081
3-hydroxy-1,6-naphthyridin-2(1H)-one hydrobromide
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.0002 - 0.000424
3-hydroxy-1,8-naphthyridin-2(1H)-one hydrobromide
0.00847
3-hydroxy-5-methylquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.000215
3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.000094
3-hydroxyquinolin-2-one
Rattus norvegicus
-
at pH 8.2 and 37°C
0.1
4-(trifluoromethyl)-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
IC50 above 0.1 mM
0.00782
4-fluoro-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.000114
4H-thieno [3,2-b]pyrrole-5-carboxylic acid
Rattus norvegicus
-
-
0.000145
4H-thieno[3,2-b] pyrrole-5-carboxylic acid
Rattus norvegicus
-
-
0.000599
5-bromo-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.00004
5-chloro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.000004
5-chloro-6-fluoro-3-hydroxy-1,8-naphthyridin-2(1H)-one hydrobromide
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.00005
5-chloro-6-fluoro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.003665
5-ethyl-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.000196
5-fluoro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.00151
5-iodo-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.000901
5-methylpyrazole-3-carboxylic acid
Rattus norvegicus
-
-
0.00295
5-nitro-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.005
6-(trifluoromethyl)-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.00009 - 0.000188
6-chlorobenzo[d]isoxazol-3-ol
0.1
6-ethoxy-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
IC50 above 0.1 mM
0.000444
6-fluoro-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.000308
6-fluoro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.00257
6-methoxy-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.000269
6-methyl-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.000722
6-nitro-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.00416
7-chloro-8-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
Rattus norvegicus
-
at pH 8.2 and 37°C
0.023
7-fluoro-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
-
0.001445
7-fluoro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.1
7-fluoro-6-(trifluoromethyl)-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
IC50 above 0.1 mM
0.00015
7-fluoro-8-methyl-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
Rattus norvegicus
-
at pH 8.2 and 37°C
0.1
7-methyl-1,2-benzisoxazol-3-ol
Rattus norvegicus
-
IC50 above 0.1 mM
0.00224
8-bromo-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
Rattus norvegicus
-
at pH 8.2 and 37°C
0.00799
8-bromo-7-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
Rattus norvegicus
-
at pH 8.2 and 37°C
0.00014
8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione
Rattus norvegicus
-
at pH 8.2 and 37°C
0.00872
8-chloro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.00018
8-fluoro-3-hydroxyquinolin-2(1H)-one
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.00188
benzo[d]isoxazol-3-ol
Rattus norvegicus
-
-
0.0002
3-hydroxy-1,8-naphthyridin-2(1H)-one hydrobromide
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.000424
3-hydroxy-1,8-naphthyridin-2(1H)-one hydrobromide
Rattus norvegicus
-
pH 8.5, recombinant enzyme, with substrate D-serine
0.00009
6-chlorobenzo[d]isoxazol-3-ol
Rattus norvegicus
-
at pH 8.2 and 37°C
0.000188
6-chlorobenzo[d]isoxazol-3-ol
Rattus norvegicus
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Dememes, D.; Mothet, J.P.; Nicolas, M.T.
Cellular distribution of d-serine, serine racemase and d-amino acid oxidase in the rat vestibular sensory epithelia
Neuroscience
137
991-997
2006
Rattus norvegicus
brenda
Maekawa, M.; Okamura, T.; Kasai, N.; Hori, Y.; Summer, K.H.; Konno, R.
D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity
Chem. Res. Toxicol.
18
1678-1682
2005
Rattus norvegicus
brenda
Wu, M.; Zhou, X.J.; Konno, R.; Wang, Y.X.
D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminase
Clin. Exp. Pharmacol. Physiol.
33
1042-1046
2006
Rattus norvegicus
brenda
Tanaka, H.; Yamamoto, A.; Ishida, T.; Horiike, K.
Simultaneous measurement of D-serine dehydratase and d-amino acid oxidase activities by the detection of 2-oxo-acid formation with reverse-phase high-performance liquid chromatography
Anal. Biochem.
362
83-88
2007
Gallus gallus, Rattus norvegicus
brenda
Hashimoto, A.; Yoshikawa, M.; Andoh, H.; Yano, H.; Matsumoto, H.; Kawaguchi, M.; Oka, T.; Kobayashi, H.
Effects of MK-801 on the expression of serine racemase and D-amino acid oxidase mRNAs and on the D-serine levels in rat brain
Eur. J. Pharmacol.
555
17-22
2007
Rattus norvegicus
brenda
Pollegioni, L.; Piubelli, L.; Sacchi, S.; Pilone, M.S.; Molla, G.
Physiological functions of D-amino acid oxidases: from yeast to humans
Cell. Mol. Life Sci.
64
1373-1394
2007
Chlorella vulgaris, Rattus norvegicus (O35078), Sus scrofa (P00371), Homo sapiens (P14920), Homo sapiens, Mus musculus (P18894), Rhodotorula toruloides (P80324), Cyprinus carpio (Q6TGN2), Trigonopsis variabilis (Q99042), [Candida] boidinii (Q9HGY3)
brenda
Adage, T.; Trillat, A.C.; Quattropani, A.; Perrin, D.; Cavarec, L.; Shaw, J.; Guerassimenko, O.; Giachetti, C.; Greco, B.; Chumakov, I.; Halazy, S.; Roach, A.; Zaratin, P.
In vitro and in vivo pharmacological profile of AS057278, a selective D-amino acid oxidase inhibitor with potential anti-psychotic properties
Eur. Neuropsychopharmacol.
18
200-214
2008
Rattus norvegicus, Homo sapiens (P14920), Homo sapiens
brenda
Ferraris, D.; Duvall, B.; Ko, Y.S.; Thomas, A.G.; Rojas, C.; Majer, P.; Hashimoto, K.; Tsukamoto, T.
Synthesis and biological evaluation of D-amino acid oxidase inhibitors
J. Med. Chem.
51
3357-3359
2008
Rattus norvegicus
brenda
Yoshikawa, M.; Shinomiya, T.; Takayasu, N.; Tsukamoto, H.; Kawaguchi, M.; Kobayashi, H.; Oka, T.; Hashimoto, A.
Long-term treatment with morphine increases the D-serine content in the rat brain by regulating the mRNA and protein expressions of serine racemase and D-amino acid oxidase
J. Pharmacol. Sci.
107
270-276
2008
Rattus norvegicus (O35078)
brenda
Konno, R.; Okamura, T.; Kasai, N.; Summer, K.H.; Niwa, A.
Mutant rat strain lacking D-amino-acid oxidase
Amino Acids
37
367-375
2009
Rattus norvegicus
brenda
Williams, M.
Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges
Biochem. Pharmacol.
78
1360-1365
2009
Homo sapiens, Rattus norvegicus
brenda
Duplantier, A.J.; Becker, S.L.; Bohanon, M.J.; Borzilleri, K.A.; Chrunyk, B.A.; Downs, J.T.; Hu, L.Y.; El-Kattan, A.; James, L.C.; Liu, S.; Lu, J.; Maklad, N.; Mansour, M.N.; Mente, S.; Piotrowski, M.A.; Sakya, S.M.; Sheehan, S.; Steyn, S.J.; Strick, C.A.; Williams, V.A.; Zhang, L.
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors
J. Med. Chem.
52
3576-3585
2009
Rattus norvegicus, Homo sapiens (P14920), Homo sapiens
brenda
Ono, K.; Shishido, Y.; Park, H.K.; Kawazoe, T.; Iwana, S.; Chung, S.P.; Abou El-Magd, R.M.; Yorita, K.; Okano, M.; Watanabe, T.; Sano, N.; Bando, Y.; Arima, K.; Sakai, T.; Fukui, K.
Potential pathophysiological role of D-amino acid oxidase in schizophrenia: immunohistochemical and in situ hybridization study of the expression in human and rat brain
J. Neural Transm.
116
1335-1347
2009
Homo sapiens, Rattus norvegicus (O35078)
brenda
Smith, S.M.; Uslaner, J.M.; Yao, L.; Mullins, C.M.; Surles, N.O.; Huszar, S.L.; McNaughton, C.H.; Pascarella, D.M.; Kandebo, M.; Hinchliffe, R.M.; Sparey, T.; Brandon, N.J.; Jones, B.; Venkatraman, S.; Young, M.B.; Sachs, N.; Jacobson, M.A.; Hutson, P.H.
The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine
J. Pharmacol. Exp. Ther.
328
921-930
2009
Homo sapiens, Rattus norvegicus
brenda
Zhao, W.J.; Gao, Z.Y.; Wei, H.; Nie, H.Z.; Zhao, Q.; Zhou, X.J.; Wang, Y.X.
Spinal D-amino acid oxidase contributes to neuropathic pain in rats
J. Pharmacol. Exp. Ther.
332
248-254
2009
Rattus norvegicus
brenda
Zain, Z.M.; ONeill, R.D.; Lowry, J.P.; Pierce, K.W.; Tricklebank, M.; Dewa, A.; Ab Ghani, S.
Development of an implantable D-serine biosensor for in vivo monitoring using mammalian D-amino acid oxidase on a poly (o-phenylenediamine) and Nafion-modified platinum-iridium disk electrode
Biosens. Bioelectron.
25
1454-1459
2010
Rattus norvegicus
brenda
Konno, R.; Hamase, K.; Maruyama, R.; Zaitsu, K.
Mutant mice and rats lacking D-amino acid oxidase
Chem. Biodivers.
7
1450-1458
2010
Mus musculus, Rattus norvegicus
brenda
Chung, S.P.; Sogabe, K.; Park, H.K.; Song, Y.; Ono, K.; Abou El-Magd, R.M.; Shishido, Y.; Yorita, K.; Sakai, T.; Fukui, K.
Potential cytotoxic effect of hydroxypyruvate produced from D-serine by astroglial D-amino acid oxidase
J. Biochem.
148
743-753
2010
Rattus norvegicus
brenda
Frattini, L.F.; Piubelli, L.; Sacchi, S.; Molla, G.; Pollegioni, L.
Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase
FEBS J.
278
4362-4373
2011
Rattus norvegicus
brenda
Luks, L.; Sacchi, S.; Pollegioni, L.; Dietrich, D.R.
Novel insights into renal D-amino acid oxidase accumulation propiverine changes DAAO localization and peroxisomal size in vivo
Arch. Toxicol.
91
427-437
2017
Rattus norvegicus
brenda
Xie, D.; Lu, J.; Xie, J.; Cui, J.; Li, T.F.; Wang, Y.C.; Chen, Y.; Gong, N.; Li, X.Y.; Fu, L.; Wang, Y.X.
Discovery and analgesic evaluation of 8-chloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione as a novel potent D-amino acid oxidase inhibitor
Eur. J. Med. Chem.
117
19-32
2016
Homo sapiens, Rattus norvegicus, Sus scrofa
brenda